Search Results
Eckel Invited Lecture: Evaluating and Treating "Residual Risk" in ASCVD | Michael J. Blaha, MD, MPH
New evidence in heart disease - Reducing residual risk
Optimizing Lipid Risk Factors: Focus on Residual Risk, Dr. David Vorchheimer
Residual cardiovascular risk. What is the role of icosapent ethyl?
Symposium On: Residual CV Risk: IS LDL-C Target Enough?
Reframing Atherosclerotic Cardiovascular Risk: The Case for Novel Risk Markers, June 25, 2021
Grand Rounds 2024.02.14
TERCER ATENEO SOCIEDAD ARGENTINA DE LIPIDOS 2022
